PFREUNDSCHUH PETER P. — SEC Form 4 filings
SEC reporting owner CIK 1585839. 5 Form 4 filings on record with FilingPulse; latest filed 2025-09-18.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-02-16 to 2025-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 3,764 shares, $28,079 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 3,764 shares @ $7.46 ($28,079) in Voyager Therapeutics, Inc., filed 2024-02-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | Chief Financial Officer | 2 | — | 1 leg · 3,764 sh · $28,079 | 2 |
| Y-mAbs Therapeutics, Inc. (YMAB) | EVP, CFO and Treasurer | 3 | — | — | 9 |
Form 4 filings — PFREUNDSCHUH PETER P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-09-18 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Disposition to issuer (D): 77,800 · Disposition to issuer (D): 170,000 (derivative) · Disposition to issuer (D): 63,500 (derivative) · Disposition to issuer (D): 15,900 (derivative) · Disposition to issuer (D): 15,900 (derivative) | EDGAR |
| 2025-01-22 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Grant/award (A): 31,800 @ $0 · Grant/award (A): 63,500 (derivative) @ $0 | EDGAR |
| 2024-07-12 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Grant/award (A): 46,000 @ $0 · Grant/award (A): 170,000 (derivative) @ $0 | EDGAR |
| 2024-02-22 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 3,764 @ $7.46 | EDGAR |
| 2024-02-16 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 30,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1585839 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →